avatarDr. ADAM TABRIZ

Summary

The website content discusses the integration of genomics into healthcare to achieve personalized medicine, emphasizing the need for technology, strategy, and a free-market system to deliver high-quality, individualized care.

Abstract

The article "Genomics and the Personalization of Healthcare" delves into the evolving landscape of medicine, where every individual's unique characteristics necessitate a tailored approach to treatment. It highlights the importance of genomics as a cornerstone of personalized healthcare, leveraging technologies such as intelligent polymers, immunotherapy, and biomarker immunoassays. The author advocates for a healthcare delivery model that aligns with a free-market system, unencumbered by pluralistic or populist biases, and suggests that the future of medicine lies in precision treatment, facilitated by genomics and artificial intelligence. The article also touches on the challenges of integrating genomics with current reimbursement models and the need for a multidisciplinary approach to overcome these obstacles, aiming to create a healthcare system that transcends geographic and socioeconomic barriers.

Opinions

  • Medicine is inherently complex but healthcare delivery does not have to be complicated.
  • The effectiveness of population health models is questioned in light of value-based physician reimbursement and MACRA.
  • Personalized medicine should be considered a separate branch of healthcare, encompassing individualized treatment, health information, reimbursement coverage, and clinical interaction.
  • Genomics represents the pinnacle of personalized treatment delivery and should be integrated with artificial intelligence for optimal results.
  • The precision of personalized care is enhanced by complementary technologies such as smart polymers and blockchain.
  • The value of healthcare is determined by the quality of service delivered, which must be reformed, equipped, transparent, and scientifically appropriate.
  • A competitive environment, high-level government oversight, and diverse options are necessary for the successful implementation of precision medicine.
  • Stakeholders must take charge of the design, validation, and quality assurance of precision medicine to ensure its correct implementation and control.
  • A platform is needed to combine multidisciplinary efforts and multi-modular technology to channel personalized care to individual patients, physicians, and

Genomics and the Personalization of Healthcare

Genomics and the Personalization of Healthcare, precision medicine

Medicine is the science of relativity where every individual is unique, and every scenario and case is different. Every factor, from molecules to genes, psychology to physics, environmental to social, contributes to the diversity of medical delivery. Medicine is complex, but that doesn't mean healthcare must be complicated.

Every medical case can be taken as a textbook, but delivery can be seamless between the patient, physician, or provider. The right technology and strategy have become vital, especially with the advent of value-based physician reimbursement, Medicare Access, and the CHIP Reauthorization Act of 2015 (MACRA). The measures question the effectiveness of the population health model in ensuring the necessary prerequisites which define the quality and ultimately the value of service provided to the patient.

We can achieve effective delivery by providing healthcare that follows the free market system without pluralistic and populist bias. Thus, we can entail the production of services and products by pharmaceutical and technological companies, the manufacturing and sale of medical equipment by private companies, and the training, marketing, and practice of medical practitioner skills and labor.

Personalization of Medicine and Genomics

We can reach our target by using and improvising the tools as healthcare is not a destination but a journey where the doctor walks with the patient. The physician customizes the experience using required resources, giving birth to the personalization of healthcare.

The definition of personalized medicine has gone through many changes over the years, with the latest focusing on technologies that deliver precision treatment to patients like genomics, intelligent polymers, immunotherapy, biomarker immunoassays, and so on.

My prerogative is that personification of the practice of medicine becomes a separate branch that deals exclusively with the individual, and the care provided becomes personalized healthcare. Personalized medicine, personalized health information, personalized reimbursement coverage, and personalized clinical interaction are prerequisites for authentic customized care.

For the sake of the current discussion, I would like to concentrate on "personalized medicine" and genomics which are within the scope of the article.

Genomics is a multidisciplinary approach comprised of the science of structure, function, evolution, mapping, and editing of genetic building blocks called Genome. It can be considered the golden standard of future medicine as it represents the epitome of personalization of treatment delivery. I want to call it the artificial intelligence (AI) or Precision medicine of biotechnology!

Extracting data from the different utility branches of genomics like medicine, anthropology, and social sciences and channeling it through optimally designed, validated, and quality-proofed artificial intelligence algorithms will unleash personalized medicine and personalized healthcare.

For example, being able to deliver precise treatment for an exact duration through an accurate method and does not only maximizes the outcome but also minimizes the side effects. Also, you can't expect a unique cancer treatment outcome through conventional means like chemotherapy, radiation, and surgery, as every individual comes with a different genetic structure.

In the same way, you can't reduce the tolerance to specific medications that the doctor would have prescribed at the same rate despite knowing that 10 to 20 % of the patients will have no response or even face untoward side effects.

Genomics is a subcategory of technologies that open many doors to personalized care; however, its precision is also determined by complementary technologies like "smart polymers" for tissue generation and controlled drug delivery or Blockchain and machine learning for incorporating social, environmental, and emotional criteria.

As I have said in my previous articles, the value of healthcare can only be determined by the quality of medical service delivered at a given place and time based on available resources perceived by the individual patient and acknowledged by the provider or physician. Therefore, genuinely personalized healthcare doesn't only need a village to heal one patient- it has to be reformed, equipped, transparent, and scientifically appropriate! Only then can we even think of delivering quality healthcare with the personalization of medicine?

Genomics is the future, and a personalized delivery model is a way to go. But we must remember that genomics in the context of the population health model and current reimbursement challenges will not go down a smooth road. We will encounter hybrid models of personalized approach, which are nothing new, as we have gone through similar experiences in the past. But full personalization and adapting of Hippocratic medicine of the 21st Century by reversing 18th Century population healthcare model will be inevitable.

Political partisanship and hybrid market structure will only give rise to pushbacks based on cost and delivery criteria.

What is the Solution?

We have to ensure a competitive environment, a high level of government oversight and introduce more options without restricting the driving factors. I don't want to go into the cost details as it is out of the scope of this article. But history has revealed time and time again that a free, transparent market and technology work well to deliver high-quality, affordable services and products at every industry level only if coupled with "high-level" government intervention.

One downside is that precision medicine and personalization of medicine are only possible through correct implementation and control. It would be best if you had extreme discipline, quality assurance, and organization for it to function optimally.

As healthcare stakeholders, we must embrace the fact and take charge of those designs, validations, and quality assurance. We need a platform to tie all the components of precision medicine together. We need a platform that combines multidisciplinary professional efforts with multi-modular technology platforms and channels it to individual patients, physicians, and stakeholders. The result will lead to customized medical care for individual patients and create a niche environment. Based on that, we can create a healthcare system that goes beyond geographic and socioeconomic boundaries, evolving realistically into more sustainable healthcare for the masses.

Health
Genomics
Personalized Medicine
Healthcare
Healthcare Technology
Recommended from ReadMedium